Ismael F. Millan-Aomar

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Clinical ultrasound for the characterisation of obesity: beyond the body mass index.

Clinical ultrasound for the characterisation of obesity: beyond the body mass index.

Journal: Revista clinica espanola
Published: June 02, 2025

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study.

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study.

Journal: PloS one
Published: November 30, 2022

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.

Journal: Medicina clinica (English ed.)
Published: October 17, 2022

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.

Journal: Medicina clinica
Published: April 24, 2022

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

Journal: Medicina clinica
Published: April 16, 2022

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.

Journal: Medicina clinica (English ed.)
Published: April 16, 2022

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

Journal: Reumatologia clinica
Published: February 15, 2022

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment.

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment.

Journal: Reumatologia clinica
Published: January 05, 2022

COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination

COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination

Journal: Revista clinica espanola
Published: June 10, 2021

COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination.

COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination.

Journal: Revista clinica espanola
Published: May 13, 2021

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation.

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation.

Journal: The Lancet. Rheumatology
Published: March 30, 2021

Caution with the use of dexamethasone in patients with COVID-19 in its initial phases.

Caution with the use of dexamethasone in patients with COVID-19 in its initial phases.

Journal: Revista clinica espanola
Published: February 20, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026